CABA Cabaletta Bio Inc
Company Analysis
Latest News
🔴 Cabaletta Bio is trading 5.52% down today as broader markets weaken
Cabaletta Bio is trading at $2.36, down 5.52%, after opening-session weakness on September 23, 2026, amid broader market pressure. - The Nasdaq is down 1.10%...
🟢 Cabaletta Bio is trading 5% up in pre-market amid major U.S. indices rising more than 0.5%
Cabaletta Bio is trading at $2.68 (+5.10%) in pre-market amid broader risk-on sentiment. - No new company-specific announcement dated September 21, 2026 was...
🟢 Cabaletta Bio is trading 8.29% up in after-hours trading; no clear company-specific announcement identified
Cabaletta Bio is trading 8.29% up at $2.70 after closing at $2.49 on September 16, 2026; no clear company-specific announcement explaining the after-hours move...
🔴 Cabaletta Bio is trading 10.1% down today amid sector-led biotech weakness
Cabaletta Bio is trading at $2.62, declining -10.14% alongside weaker biotech sentiment and a 2.11% drop in the XBI biotech ETF. - The move follows...
🔴 Cabaletta Bio falls 5.3% — Biotech Sector Declines on Key Drug Trial Failure and Shifting Investor Sentiment
With Biotech (XBI) down 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...
Cabaletta Bio Pockets $128 Million From Expiring Warrants — But Can Cash Alone Cure a Stock Trading Below Its Exercise Price?
Shares of Cabaletta Bio rose 7.3% to $2.93 after the autoimmune-focused biotech disclosed it collected approximately $128.2 million in gross proceeds from...
🟢 Cabaletta Bio is trading 10.44% up today after $128.2 million in warrant exercises
Cabaletta Bio is trading at $3.02, up +10.44%, after reporting approximately $128.2 million in aggregate gross proceeds from common-stock warrant exercises...
🟢 Cabaletta Bio is trading 7.33% up today after announcing approximately $128.2 million from warrant exercises
Cabaletta Bio is trading 7.33% up now at $2.93 after announcing approximately $128.2 million in gross proceeds from common-stock warrant exercises that expired...
Cabaletta Bio Announces ~$128.2M in Gross Proceeds from Warrant Exercises
Cabaletta Bio announced the final results from the exercise of its common stock warrants, which expired on September 12, 2026. The warrants, originally issued...
Cabaletta Bio Drops to Strong Sell Rating, Signaling Significant Downside Potential
Wall Street Zen downgraded Cabaletta Bio Inc. (NASDAQ:CABA) from sell to strong sell on Saturday, September 12, 2026. The research note indicates the firm...
🟢 Cabaletta Bio is trading 5% up today amid broader risk-on sentiment
Cabaletta Bio is trading 5% up at $2.88, most likely reflecting broader risk-on market sentiment after rebounding from a 5.84% decline on September 10. -...
🔴 Cabaletta Bio is trading 5.5% down today amid hotter-than-expected wholesale inflation
Cabaletta Bio is trading 5.5% down at $2.75, pressured by a broader selloff tied to hotter-than-expected wholesale inflation. - The decline extends after...
🔴 Cabaletta Bio is trading 10.1% down today as Brent crude exceeds $100 per barrel
Cabaletta Bio is trading 10.1% down at $2.94 amid broad risk-off pressure linked to escalating U.S.-Iran tensions and Brent crude exceeding $100 per barrel. -...
🔴 Cabaletta Bio is trading 5% down today amid oil prices exceeding $100 per barrel
Cabaletta Bio is trading 5.17% down now at $3.10 amid broad risk-off trading tied to escalating U.S.-Iran tensions and oil prices exceeding $100 per barrel. -...
🔴 Cabaletta Bio is trading 5% down today amid broad risk-off and geopolitical pressure
Cabaletta Bio is trading 5.19% down now at $3.29 after a broad risk-off session marked by rising oil prices, Middle East tensions, and weaker major indexes. -...
BlackRock buys 6.6% stake in Cabaletta Bio, backing autoimmune cell therapy
BlackRock Inc. acquired a new stake in Cabaletta Bio, Inc. during the second quarter. The asset manager purchased 10,754,701 shares. A September 2, 2026, SEC...
🟢 Cabaletta Bio is trading 6.21% up today as XBI rises 2.75%
Cabaletta Bio is trading at $3.50 (+6.21%), with broader biotech strength providing the clearest near-term context. • XBI is up 2.75%, alongside the gain. •...
🟢 Cabaletta Bio is trading 5% up today
Cabaletta Bio is trading at $3.27, up 5.05% now, with no clear company-specific catalyst confirmed for September 1, 2026. - Cabaletta Bio announced upcoming...
🔴 Cabaletta Bio is trading 5.1% down in pre-market as Nasdaq Composite falls 0.53%
Cabaletta Bio is trading 5.1% down at $2.95 as broader market sentiment weakens. - Shares closed at $3.11 on August 31, 2026. - No fresh company-specific...
🔴 Cabaletta Bio falls 5.2% — Biotech Sector Declines Amid Fed Rate Hike Fears
With Biotech (XBI) down 2.3%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, as measured by the XBI ETF, fell...